These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30808296)

  • 1. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.
    Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M
    BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve.
    Zaman S; McCormick L; Gooley R; Rashid H; Ramkumar S; Jackson D; Hui S; Meredith IT
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):147-154. PubMed ID: 27862860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.
    van Gils L; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Brecker S; Bapat V; Modine T; Soliman OI; Nersesov A; Allocco D; Falk V; Van Mieghem NM
    JACC Cardiovasc Interv; 2018 Jan; 11(2):119-128. PubMed ID: 29348006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
    Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
    Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
    Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
    JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Ueshima D; Nai Fovino L; Mojoli M; Napodano M; Fraccaro C; Tarantini G
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E159-E167. PubMed ID: 30019825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty Using a New Generation Valve.
    Aalaei-Andabili SH; Beaver TM; Bavry AA; Petersen JW; Karimi A; Wayangankar S; Arnaoutakis G; Anderson RD
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1100-1104. PubMed ID: 30826204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and 5-Year Clinical Outcomes of Pacemaker After TAVR: Analysis From the PARTNER 2 SAPIEN 3 Registries.
    Chen S; Dizon JM; Hahn RT; Pibarot P; George I; Zhao Y; Blanke P; Kapadia S; Babaliaros V; Szeto WY; Makkar R; Thourani VH; Webb JG; Mack MJ; Leon MB; Kodali S; Nazif TM
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1325-1336. PubMed ID: 38866455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.
    Falk V; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Dawkins KD; Van Mieghem NM
    Eur Heart J; 2017 Dec; 38(45):3359-3366. PubMed ID: 28651336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.